Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The University of Oxford has awarded the title of Associate Professor to seven senior researchers at NDORMS, and three University Research Lecturer titles.

Top row l-r: Laura Coates, Marco Fritzsche, Stephen Gwilym, Pierre-Alexis Mouthuy, Tal I Arnon. Bottom row l-r: Susan Dutton, Rafael Pinedo-Villanueva, David Keene, Sara Khalid, Adam Cribbs

The titles have been conferred in recognition of the department’s excellence in research and teaching – and our congratulations go to:

Laura Coates, Associate Professor
Professor Coates' research focuses on treatment of psoriatic arthritis in patients. She leads a clinical trial to establish optimal care pathways for newly diagnosed patients, and also chairs the British Psoriatic Arthritis Consortium to advance best practice in the field.

Marco Fritzsche, Associate Professor
Professor Fritzsche's research focuses on biophysics and mechanobiology and the impact they have on the human immune system. For this mission, his lab is developing state-of-the-art quantitative methodologies to advance the study of living immune cells.

Stephen Gwilym, Associate Professor
Professor Gwilym's research focuses on how we can optimise patients' outcomes who sustain upper limb trauma. His work has resulted in recent research grants from national and international funders, as well as leading the academic trainee programme in Trauma & Orthopaedics in Oxford.

Pierre-Alexis Mouthuy, Associate Professor
Professor Mouthuy's research is in the area of musculoskeletal tissue engineering. His lab is developing biomaterials and bioreactor systems for soft tissue repair applications. He leads a programme of research investigating the use of humanoid robots to engineer tendon tissue and is contributing to the translation of two new implants designed for patients with rotator cuff tears to clinical trials.

Tal I Arnon, Associate Professor
Professor Arnon's research explores mechanisms that regulate immune cell trafficking and B cell-mediated immunity. She came to Oxford on a Kennedy Trust for Rheumatology Research (KTRR) Senior Research Fellowship and her lab has funding from the Wellcome Trust.

Susan Dutton, Associate Professor
Oxford Clinical Trials Research Unit Lead Statistician, Professor Dutton supports a number of research groups to design, conduct and analyse clinical trials. Her work extends across a number of musculoskeletal themes, and she shares her knowledge of conducting trials through her teaching.

Rafael Pinedo-Villanueva, Associate Professor
Professor Pinedo-Villanueva explores the effects that diseases have on people's health and quality of life, and his research informs decisions made by patients and healthcare systems given their limited resources. His work is focused mainly in musculoskeletal conditions, particularly fracture prevention.

David Keene, University Research Lecturer
Dr Keene's research focusses on optimising outcomes and rehabilitation for people with musculoskeletal injuries. His work focuses on the evaluation of treatments by conducting clinical trials in the UK National Health Service.

Sara Khalid, University Research Lecturer
Dr Khalid’s research applies machine learning and statistics to routinely collected healthcare data, in order to derive data-driven insights that can lead to furthering our understanding of known phenotypes and uncover hidden ones, as well as to do personalised prediction of health risks. Her work has a particular focus on epidemiology for planetary health, and she teaches a number of courses at NDORMS and University-wide.  

Adam Cribbs, University Research Lecturer
As a computational biologist, Dr Cribbs has a broad interest in systems biology, immunology and epigenetics. His work has helped facilitate drug discovery for a range of disease models, and shares this experience in his role as group leader at the Botnar Research Centre.

NDORMS Head of Department Professor Andrew Carr commented: “These titles of distinction are justly deserved and recognise a significant and sustained contribution to research by all concerned. I am delighted to be able to pass my personal congratulations."

Similar stories

Small mechanical forces in immune cells measured at unprecedented sensitivity

Kennedy Main Research

Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.

NDORMS researchers awarded for Dupuytren research

Awards Hand Kennedy Main

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF

Arthritis Kennedy Main

New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.